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Background:We recently reported that ER stress plays a key role in vascular endothelial dysfunction during hy-
pertension. In this studywe aimed to elucidate themechanisms bywhich ER stress induction and oxidative stress
impair vascular endothelial function.Methodology/principal ﬁndings:We conducted in vitro studies with primary
endothelial cells from coronary arteries stimulatedwith tunicamycin, 1 μg/mL, in the presence or absence of two
ER stress inhibitors: tauroursodeoxycholic acid (Tudca), 500 μg/mL, and 4-phenylbutyric acid (PBA), 5 mM. ER
stress induction was assessed by enhanced phosphorylation of PERK and eIF2α, and increased expression of
CHOP, ATF6 and Grp78/Bip. The ER stress induction increased p38 MAPK phosphorylation, Nox2/4 mRNA levels
and NADPH oxidase activity, and decreased eNOS promoter activity, eNOS expression and phosphorylation, and
nitrite levels. Interestingly, the inhibition of p38MAPK pathway reduced CHOP and Bip expressions enhanced by
tunicamycin and restored eNOS promoter activation as well as phosphorylation. To study the effects of ER stress
induction in vivo, we used C57BL/6J mice and p47phox−/− mice injected with tunicamycin or saline. The ER
stress induction in mice signiﬁcantly impaired vascular endothelium-dependent and independent relaxation in
C57BL/6J mice compared with p47phox−/−mice indicating NADPH oxidase activity as an intermediate for ER
stress in vascular endothelial dysfunction. Conclusion/signiﬁcance:We conclude that chemically induced ER stress
leads to a downstream enhancement of p38MAPK and oxidative stress causing vascular endothelial dysfunction.
Our results indicate that inhibition of ER stress could be a novel therapeutic strategy to attenuate vascular dys-
function during cardiovascular diseases.© 2014 Elsevier B.V. All rights reserved.1. Introduction
The endoplasmic reticulum (ER) is the cell organelle where protein
translation, folding and trafﬁcking occur. Maintenance of calcium
homeostasis, and production and storage of glycogen as well as other
macromolecules also take place in the ER. Additionally, the ER is the
early response site to cellular stresses [1,2]. When there is a biological
stress that impairs ER homeostasis or function, the cell responds to
the increasing presence of unfolded proteinswithin the ER by activating
a complex signaling network called the unfolded protein response
(UPR), which attempts to restore normal ER function [3]. The ER stress
is caused by multiple factors including high glucose or energy depriva-
tion, oxidative stress, hypoxia, calcium overload, expression of mutantical Sciences, Eastern Virginia
446 5278.proteins incompatible with folding and the exposure to chemicals
such as thapsigargin or tunicamycin [4]. Additionally, it has been
shown that obesity, diabetes mellitus, neurodegenerative disorders,
viral infection, cancer, inﬂammatory conditions and cardiovascular
disorders are associated with ER stress induction [5–8].
Recent studies have shown a relationship between ER stress and ox-
idative stress in cardiovascular pathology [9–11]. While oxidative stress
has been implicated in the apoptotic process triggered by ER stress, the
source and its relationshipwith ER stress are gaps in knowledge that re-
main to be studied [12,13]. The nicotinamide adenine dinucleotide
phosphate (NADPH) oxidase is considered one of the main sources im-
plicated in producing cellular reactive oxygen species (ROS) [14]. The ER
stress signaling involving calcium and Ca2+/calmodulin-dependent
protein kinase II (CaMKII) activates NADPH oxidase and increases oxi-
dative stress, which are necessary for ER stress-induced apoptosis
[15,16]. However, the issue of whether NADPH oxidase plays a role up-
stream or downstream to ER stress-induced cardiovascular dysfunction
remains controversial.
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characterized by reduced eNOS activity and/or expression and de-
creased nitric oxide (NO) bioavailability resulting in part fromenhanced
oxidative stress [21]. The expression of eNOS is regulated by multiple
mechanisms that include transcriptional and post-transcriptional regu-
lation of mRNA, and post-translational regulation of the protein func-
tion [22]. It is known that Akt activity enhances phosphorylation of
eNOS, which is antagonized by the activation of p38 MAPK [23–26].
The negative effect of ER stress induction on eNOS expression has
been recently described in endothelial cells in a model of isolated pul-
monary hypertension, and in muscle from CHOP−/−mice [27,28].
Because endothelial nitric oxide synthase (eNOS) plays an important
role in maintaining blood pressure and vascular function, our aim is to
determine the cellularmechanisms that linkER stress to oxidative stress
and how it affects eNOS expression and activity in vascular endothelial
cell.
In the present study,we show that ER stress induction by tunicamycin
regulates NADPH oxidase and endothelial nitric oxide synthase (eNOS)
activity as well as gene expression. We also show that p47phox deﬁ-
ciency prevents ER stress-induced vascular dysfunction.
2. Results
2.1. ER stress induction by Tunicamycin enhances oxidative stress in
coronary endothelial cells
The induction of ER stress in coronary endothelial cells exposed to
tunicamycin for 6 h was determined by the expression of ER stress
markers. Tunicamycin increased phosphorylated protein kinase-like en-
doplasmic reticulum kinase (PERK), phosphorylated eukaryotic initia-
tion factor 2α (P-eIF2α), 78 kDa glucose-regulated protein (Grp78)/
Bip, C/EBP homologous protein (CHOP) and activating transcription
factor 6 (ATF6) protein expression (Fig. 1A–E). This was accompanied
with an increase in CHOP and ATF6 gene expressions (Fig. 1F, G). The
enhanced ER stress marker expression was reduced when endothelial
cells were pre-treated with ER stress inhibitors (Tudca and PBA). We
did not observe changes in the expression of ER stress markers in endo-
thelial cells incubated with vehicle and ER stress inhibitors indicating
that the effect of Tudca and PBA on ER stress inhibition is speciﬁc
(Fig. 1A–G).
The incubation with tunicamycin for 6 h barely impaired DNA stud-
ied by the Comet single cell electrophoresis assay. This impairment was
prevented after ER stress inhibition by Tudca (Fig. S1).
To determine whether ER stress enhances oxidative stress, we mea-
suredNox2/4 expression, NADPH oxidase activity and superoxide anion
production in cells exposed to tunicamycin and pre-treated with or
without ER stress inhibitors or apocynin. Thus, Fig. 2 illustrates that
ER stress induction triggered an increase in mRNA levels of Nox2
and Nox4 (Fig. 2A, B), and increased NADPH oxidase activity (Fig. 2C)
and dihydroethidium (DHE) staining (Fig. 2D), which were prevented
when endothelial cells were pre-treated with ER stress inhibitors or
apocynin. Interestingly, the down-regulation of Nox2 and Nox4 by spe-
ciﬁc siRNAs, which led to a 50% decrease in Nox2 and Nox4 basal gene
expression, prevented the increase in NADPH oxidase activity and in
their mRNA levels in response to tunicamycin (Fig. 2E–G). Transfection
of endothelial cells with scrambled RNA (scr) did not change Nox2 or
Nox4 mRNA level (Fig. 2E–G).
2.2. ER stress induction by tunicamycin reduces eNOS activity and
expression in coronary endothelial cells
To determine how ER stress induction affects endothelial function,
eNOS expression and activity were studied in endothelial cells. For
this purpose, we measured eNOS promoter activity, as well as its gene
and protein expression after incubation with tunicamycin for 6 h.Transient transfection of endothelial cells with a reporter plasmid
containing the eNOS promoter exhibited a high basal luciferase ac-
tivity that was reduced to 50% after exposure to tunicamycin. This re-
duction was prevented in cells pre-treated with Tudca (Fig. 3A). To
elucidate whether this effect was speciﬁcally dependent on ER stress
induction, we co-transfected the endothelial cells with the reporter
plasmid containing the eNOS promoter and mammalian expression
plasmids containing cDNAs encoding for murine CHOP or ATF6. In-
terestingly, luciferase activity was signiﬁcantly reduced 1.7-fold
and 1.5-fold by the overexpression of CHOP and ATF6, respectively
(Fig. 3B).
Surprisingly, the eNOSmRNA levels remained unchanged after incu-
bation with tunicamycin compared with cells incubated with vehicle
and in the presence or absence of ER stress inhibitors (Fig. 3C). Howev-
er, in a time course experiment with tunicamycin, a decrease in eNOS
gene expression at longer times than 6 h was observed (Fig. 3D).
These results were conﬁrmed by ﬂuorescence in situ hybridization
(RNA-FISH) analysis of eNOS mRNA. The ﬂuorescence quantiﬁcation
showed a decreased eNOS mRNA expression in cells incubated with
tunicamycin for 8–10 h (Fig. 3E).
The discrepancy between the reduction in promoter activity
and the sustained eNOS mRNA levels after 6 h of exposure to
tunicamycin suggested the implication of post-transcriptional regu-
latory mechanisms. To test this hypothesis, we performed an assay to
measure mRNA stability based on a time course experiment with ac-
tinomycin D (transcription inhibitor), in cells incubated with vehicle
and cells incubated with tunicamycin in the presence or absence of
Tudca. A delay in eNOS mRNA decay was observed in cells incubated
with tunicamycin compared to vehicle or cells pre-treated with
Tudca (Fig. 3F).
These results in gene expression were supported by a time depen-
dent decrease in total eNOS protein expression (Fig. 3G).
The activity of eNOS was evaluated by the expression of phos-
phorylated eNOS (P-eNOS) in Serine 1177 and by nitrite pro-
duction. The expression of active eNOS was decreased in cells
incubated with tunicamycin compared to cells incubated with vehi-
cle and cells pre-treated with Tudca (Fig. 3H). Moreover, nitrite
production measured in the supernatants of cell cultures was sig-
niﬁcantly reduced by tunicamycin in a similar way to cells incubat-
ed with L-NAME. The co-incubation with tunicamycin and L-NAME
did not have a synergistic effect on the reduction of nitrite content
(Fig. 3I).
2.3. ER stress inductionmodulates extracellular-signal related kinases 1 and
2 (ERK 1/2) and p38mitogen-activated protein kinase activity (p38MAPK)
in an opposite way
Endothelial cells exhibited a decrease in phosphorylation of
extracellular-signal related kinases 1 and 2 (P-ERK1/2) and an increase
in phosphorylation of p38 mitogen-activated protein kinase (P-p38
MAPK) after incubation with tunicamycin, which were normalized
after ER stress inhibition (Fig. 4A, B).
Due to p38MAPK activation by ER stress induction,we incubated the
endothelial cells with the p38 MAPK inhibitor, SB203580, prior to the
addition of tunicamycin to determine whether the effects observed in
eNOS activity and expression were mediated by p38MAPK. In addition,
the expression of ER stress markers in the presence of p38MAPK inhib-
itor was studied.
The p38 MAPK inhibitor restored to control levels its phosphoryla-
tion as expected; however, apocynin did not change p38 MAPK activa-
tion by tunicamycin indicating it was independent of O2– production
(Fig. 4C).
Interestingly, the reduction in eNOS phosphorylationwas prevented
by p38 MAPK inhibitor in cells exposed to tunicamycin (Fig. 4D). More-
over, in cells co-transfectedwith eNOS promoter plasmid and themam-
malian expression plasmid containing cDNA for ATF6, the reduction in
Fig. 1.ER stressmarkers expression in endothelial cells (EC). A–E. RepresentativeWestern blots and quantitative analysis of P-PERK, P-eIF2α, CHOP, ATF6 and grp78 or Bip, n=5, and; F, G.
CHOP and ATF6 mRNA levels, normalized to 18S rRNA, n = 6. The cells were incubated with 1 μg/mL tunicamycin (Tunica) for 6 h and pre-treated or not with ER stress inhib-
itors (+Tudca/+PBA) 1 h prior to add the tunicamycin. Data are expressed as mean ± SEM. *P≤ 0.05 for Tunica vs. cells treated with vehicle (C) or cells pre-treated with Tudca
or PBA (Tunica + Tudca/PBA); #P ≤ 0.05 for Tunica + Tudca/PBA vs. C or C + Tudca/PBA.
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dicate that ATF6 is regulating eNOS promoter activity by modulating
p38 MAPK action (Fig. 4E, F).We then studied whether the inhibition of p38 MAPK altered the
expression of the ER stress markers P-eIF2α, ATF6, CHOP and BiP. We
observed that the pre-incubation with p38 MAPK inhibitor did not
Fig. 2. NADPH oxidase expression/activity induction by ER stress in endothelial cells. A, B. Quantitative real time PCR assessment of Nox2 and Nox4 gene expression, normalized to 18S
rRNA, in cells treated with vehicle (C) or tunicamycin (Tunica) in the absence or presence of Tudca or PBA, n = 6. C. NADPH oxidase activity measured by lucigenin chemiluminescence
in cells treatedwith vehicle or tunicamycin in the absence or presence of Tudca or apocynin (Apo, 100 μmol/L), n= 6. D. Representative images of cells stainedwith dihydroethidiumand
ﬂuorescence signal quantiﬁcation, n = 4. E. NADPH oxidase activity measured in EC transfected with scrambled RNA (Scr), Nox2 siRNA or Nox4 siRNA, incubated with or without
tunicamycin, n= 5. F, G. Nox2 and Nox4 gene expression, normalized to 18S rRNA, in EC transfected with either Nox2 siRNA or Nox4 siRNA and incubated with or without tunicamycin,
n=6. In all experiments cells were incubatedwith tunicamycin for 6 h. Data are expressed asmean±SEM. *P≤ 0.05 for Tunica, Tunica+ Tudca/PBA or Tunica+Apo vs.C± Tudca/PBA;
$P ≤ 0.05 for Tunica + PBA vs. Tunica; &P ≤ 0.05 for Tunica vs. Tunica + Tudca/PBA or Tunica + Apo; #P b 0.05 for Nox4siRNA/Nox2siRNA ± Tunica vs. Scr.
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but reduced CHOP and Bip expressions (Fig. 4G–I).
2.4. ER stress induction in vivo: effect on vascular reactivity, eNOS and
NADPH oxidase activity and expression in vessels from C57BL/6J and
p47phox−/−mice
To determine the relationship between the ER stress response, oxi-
dative stress and vascular dysfunction, we examined endothelium-
dependent relaxation (EDR) and endothelium-independent relaxation
in aorta and in mesenteric resistance arteries (MRA) from C57BL/6J,
used as control group, and p47phox−/−mice injectedwith tunicamycin
or saline for two weeks. We selected p47phox−/− because the up-
regulation of this subunit of the NADPH oxidase complex has beenshowed to be critical in impaired endothelial dependent vasorelaxation
and in the uncoupling of eNOS [29,30].
Systolic blood pressure (SBP), measured at the end of the treatment,
showed no difference among all groups (Fig. S2). ER stress induction
in vivo by tunicamycin was assessed by increased P-eIF2α/T-eIF2α,
CHOP and ATF6 expressions in aorta and MRA from C57BL/6J (control)
and p47phox−/−mice (Fig. 5).
The mRNA levels of CHOP were increased in aorta and MRA from
control and p47phox−/−mice, injected with tunicamycin (Fig. 5B, G).
These changes in gene expression were accompanied by the corre-
sponding increase in CHOP protein by Western blot in aorta and MRA
from control and p47phox−/− mice injected with tunicamycin com-
pared to injected mice with saline (Fig. 5C, H). We also reported an in-
crease in ATF6 gene expression in aortas and MRA from control and
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companied by an increase in cleaved ATF6 protein in artery lysates
(Fig. 5E, J).
The EDR of aortas from control and p47phox−/−mice in response to
acetylcholine (ACh) was reduced by tunicamycin; however, EDR was
less impaired in p47phox−/− mice compared with control mice
(Fig. 6A). The EDR in MRA was markedly impaired in control group
while in p47phox−/− group it was just slightly reduced by tunicamycin
(Fig. 7A).
The eNOS phosphorylationwas reduced in aorta andMRA from con-
trol and p47phox−/−mice injected with tunicamycin. Total eNOS ex-
pression was similar in aortas from all groups of mice, while it was
signiﬁcantly reduced in MRA from control and p47phox−/− mice by
tunicamycin (Figs. 6C, 7C). These results in eNOS protein were con-
ﬁrmed by eNOS mRNA levels in both types of vessels (Figs. 6D, 7D).
The incubation with L-NAME abolished the relaxation in aorta and
MRA from control and p47phox−/− mice injected with saline or
tunicamycin (data not shown).
The incubation with apocynin had no effect on EDR in aorta from
control mice or p47phox−/− mice injected with tunicamycin when
compared with their correspondent groups treated with saline
(Fig. 6B). In MRA the incubation with apocynin restored the relaxation
impaired by tunicamycin in controlmice; however, it did not have anef-
fect on EDR of MRA from p47phox−/− (Fig. 7B).
An increase in Nox2 mRNA levels was detected in aortas and MRA
from control and p47phox−/−mice groups injected with tunicamycin
when compared with their homologous groups injected with saline
(Figs. 6E, 7E). Nox4 mRNA levels were similar in all groups (data notFig. 3. Effect of ER stress on eNOS activity/expression in endothelial cells. A, B. eNOS promoter ac
(C) or incubatedwith tunicamycin (Tunica)± Tudca/PBA and in cells co-transfectedwith plasm
mRNA levels, normalized to 18S rRNA, in cells with vehicle or incubatedwith tunicamycin± Tu
in a time course assay with tunicamycin, n= 5; E. Representative pictures of eNOSmRNA detec
levels in a time course experimentwith actinomycinD after incubationwith tunicamycinwith o
in a time course assay with tunicamycin, n = 4; H. Representative Western blot for phospho
incubated with tunicamycin (Tunica) ± Tudca/PBA, n = 4, and; I. nitrite production measured
in the absence or presence of Tudca, PBA, Apocynin or L-NAME (100 μmol/L), n = 6. In these e
+ Tudca; #P ≤ 0.05 for Tunica vs. Tunica + Tudca; &P ≤ 0.05 for Tunica + L-NAME vs. controshown). The NADPH oxidase activity was enhanced in arteries from
control mice injected with tunicamycin, while it did not change in
p47phox−/−mice when compared with their groups injected with sa-
line (Figs. 6F, 7F).
In regard to endothelium independent relaxation, the response
to sodium nitroprusside (SNP) in aorta and MRA was shifted to the
right in the control mice group injected with tunicamycin when
compared with the control mice group treated with saline (Fig. S3A,
C). Interestingly, endothelium independent relaxation in aorta was not
affected by tunicamycin in p47phox−/− mice, while in MRA it was
shifted to the right. The shift in MRA was more pronounced in control
mice group than in p47phox- mice group (Fig. S3B, D).
3. Discussion
We previously reported that in vivo ER stress induction by
tunicamycin was associated with impaired vascular endothelial func-
tion and an increase in NADPH oxidase activity in aorta and mesenteric
resistance arteries [31]. In the present study, we examined the mecha-
nisms by which ER stress induction leads to vascular endothelial
dysfunction. Thus, our results show that ER stress induction causes vas-
cular endothelial dysfunction through oxidative stress and p38 MAPK
dependent mechanisms.
It is well known that NADPH oxidases (Nox) are themajor source for
ROS in the cardiovascular system [32,33] and multiple independent
studies provide evidence that Nox proteins contribute to oxidative
damage in response to a wide variety of stimuli [34,35]. In the present
study, we observed an enhancement in NADPH oxidase activity intivity in transfected ECwith plasmid containing eNOSpromoter in cells addedwith vehicle
ids overexpressing CHOP and ATF6, respectively, n=5. C. Quantitative evaluation of eNOS
dca/PBA, n= 6. D. Quantitative evaluation of eNOSmRNA levels, normalized to 18S rRNA,
ted by RNA-FISH analysis with quantitative ﬂuorescence evaluation, n= 3; F. eNOSmRNA
rwithout Tudca, n=5; G. RepresentativeWestern blot for eNOS and quantitative analysis
rylated eNOS (P-eNOS), total eNOS and quantitative analysis in cells with vehicle (C) or
in supernatants of cultured EC with vehicle (C) or incubated with tunicamycin (Tunica)
xperiments cells were incubated with tunicamycin for 6 h. *P ≤ 0.05 for Tunica vs. C or C
l + L-NAME.
Fig. 3 (continued).
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increase in Nox2 and Nox4 gene expression. In addition, knockdown
of either Nox2 or Nox4 drastically reduced NADPH oxidase activity
and abolished the increments in Nox2 and Nox4 gene expression after
tunicamycin exposure, respectively, indicating that both are involved
in oxidative stress generation after ER stress induction. These results
are supported by previous studies where enhanced superoxide genera-
tion and up-regulation of Nox2, Nox4 and NADPH oxidase p47phox
subunit were associated with impaired endothelial vasorelaxation
[15,29]. In terms of vascular reactivity, the inhibition of reactive oxygen
species generation by apocynin did not affect the endothelium depen-
dent relaxation (EDR) in vessels from p47phox−/−mice, but it signiﬁ-
cantly improved EDR in control mice injected with tunicamycin. The
endothelium-independent relaxation was impaired in aorta and MRA
from control mice administration with tunicamycin, while in the
p47phox−/−mice injected with tunicamycin, only the MRA relaxation
was slightly affected indicating the importance of oxidative stress de-
rived from ER stress induction in vascular function. Furthermore, in
the present study, the absence of functional p47phox in vivo prevented
the increase in NADPH oxidase activity induced by tunicamycin in aorta
and MRA. Moreover, we found a substantial increase in Nox2 mRNA
levels in aorta and MRA from both C57BL/6J and p47phox−/− mice
treated with tunicamycin, which is consistent with our results in endo-
thelial cells. Our ﬁndings are supported by previous studieswhere Nox2
and CHOP-mediated ER stress was responsible for apoptosis in highglucose treated endothelial cells. Furthermore, a study using Nox2-
deﬁcient mice showed a reduction in CHOP expression and apoptosis
in response to ER stress induction suggesting a complex interplay be-
tween oxidative stress and ER stress [36,14]. The eNOS protein and
gene expression were reduced in MRA from tunicamycin treated mice,
while they did not change in aorta. These data indicate a differential ef-
fect in terms of mechanistic that causes vascular endothelial dysfunc-
tion between resistance arteries vs. conductance arteries.
Recently, a relationship between ER stress induction and eNOS ex-
pression has been established [28]. Indeed, we observed a decrease in
eNOS gene expression in cells subjected to tunicamycin for 6 h preceded
by the reduction in eNOS promoter activity. However, the eNOS protein
and mRNA levels remained the same at this time suggesting that expo-
sure to tunicamycin for 6 h was not sufﬁcient to produce changes in
eNOS protein. Additionally, the delay in eNOS mRNA decay in the acti-
nomycin D time course assay in cells exposed to tunicamycin indicated
an increase in eNOS mRNA stability as a compensating mechanism.
These data are supported by numerous studies that indicate post-
transcriptional mechanisms governing the eNOS expression by modu-
lating eNOS mRNA stability through the intervention of stabilizing/
destabilizing proteins binding to the 3′UTR region of the messenger
[37,38].
Recently, it has been reported that ER stress induction activates
MAPKinases [39–41]. Tunicamycin reduced ERK1/2 phosphorylation
in endothelial cells that were restored after ER stress inhibition. These
Fig. 4. Effect of p38MAPK activation by ER stress on eNOS. A, B. RepresentativeWestern blots and quantitative analysis for P-ERK 1/2 and P-p38MAPK in ECwith vehicle (C) or incubated
with tunicamycin (Tunica) in the absence or presence of Tudca or PBA, n = 5; C. Representative Western blots and quantitative analysis for P-p38 in EC treated with tunicamycin in
the absence or presence of p38 inhibitor (±p38I), SB203580 (10 μmol/L), or apocynin (Apo), n = 4; D. P-eIF2α and ATF6 and E, F. CHOP and BiP representative blots and quantitative
analysis, n = 4; G. Representative blot and quantitative data of phosphorylated eNOS, n = 4, and H. eNOS promoter activity in transiently transfected EC incubated with or without
tunicamycin ± p38I, n = 5; I. eNOS promoter activity in cells co-transfected with the plasmid expressing ATF6 ± p38I, n = 5. *P ≤ 0.05 for Tunica or Tunica + Apo vs. C; #P ≤ 0.05
for Tunica or Tunica + Apo vs. Tunica + Tudca or Tunica + p38I; &P ≤ 0.05 for eNOSp + ATF6 vs. eNOSp + ATF6 + p38I or eNOSp.
1069M. Galán et al. / Biochimica et Biophysica Acta 1843 (2014) 1063–1075results are supported by previous studies showing that ER stress induc-
tion reduces ERK1/2 activation and that TUDCA and PBA prevent cell
death by interrupting classic pathways of apoptosis and restoring ERK
activity [42–44]. In contrast, we detected an increase in p38 MAPK
phosphorylation by tunicamycin. The activation of this MAPK signaling
pathway in response to ER stress has been previously described in endo-
thelial cells stimulated with thapsigargin [45]. Interestingly, the inhibi-
tion of p38 MAPK in the presence of tunicamycin, restored eNOS
activation and normalized promoter activity suggesting that the activa-
tion of p38 MAPK by ER stress contributes to down-regulation of eNOS
expression. Our results are supported by previous studies showing the
negative effect of p38 MAPK activation on eNOS promoter regulation
[46,47]. The inhibition of p38MAPK reduced CHOP and BiP expressions
but did not affect ATF6 expression or eIF2α phosphorylation suggesting
that p38 MAPK can modulate CHOP activity and expression and its
targeted genes like BiP/GRP78 [48,49]. Moreover, the inhibition of p38MAPK in transiently transfected endothelial cells overexpressing ATF6
restored the eNOS promoter activity indicating that p38 MAPK activity
is downstream to ATF6 action.
In summary, we conclude that oxidative stress generation and p38
MAPK activation are intermediates in the impairment of vascular endo-
thelial function by chemically induced ER stress in our model. Our data
provides further insights on the complex relationship among ER stress
homeostasis, oxidative stress and endothelial cell biology.
4. Methods
4.1. Endothelial cell culture, transient transfection and Luciferase assay
Mouse coronary artery endothelial cellswere purchased in CelProgen
(San Pedro, CA, USA) andwere cultured according to themanufacturer's
instructions with CelProgen Complete Growth media. Cultures were
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Fig. 6. Endothelium dependent relaxation, eNOS and NADPH oxidase in aortas from control and p47phox−/− (p47−/−) mice. A. Endothelium dependent relaxation (EDR) in response
to ACh, n = 6; B. EDR in response to ACh in the presence of apocynin (Apo), n = 6; C, D. Western blot analysis for P-eNOS and T-eNOS, normalized to β-actin, n = 4, and eNOS mRNA
levels, normalized to 18S rRNA, n = 6; D, E. Nox2 mRNA levels, normalized to 18S rRNA, n = 6; and F. NADPH oxidase activity in tissue lysates of vessels from control and p47phox−/−
mice injected with saline or tunicamycin, n = 5. *P b 0.05 for control + Tunica or p47−/−+ Tunica vs. control and p47−/−; #P b 0.05 for control + Tunica vs. p47phox−/−+ Tunica;
$P b 0.05 for p47phox −/− vs. p47phox −/−+ Tunica.
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changed every 2 days. Conﬂuent cell monolayers were harvested by a
brief incubation with 0.25% trypsin–EDTA solution (GIBCO, Invitrogen,Fig. 5. ER stressmarkers expression in aorta andMRA. A, F.Western blot analysis and quantitati
levels, normalized to 18S rRNA, n= 6, and representative blot for CHOP protein and quantitativ
rRNA, n= 6, and representative blots for cleaved ATF6 and quantitative data respectively in aor
(Tunica), n = 4. *P b 0.05 for C + Tunica or p47phox−/−+ Tunica vs. C and p47phox−/−; # PGran Island, NY, USA) and subcultured in order to perform further exper-
iments between passages 3 and 6. The endothelial cells were incubated
with vehicle or tunicamycin (1 μg/mL) [50] for 6 h and were pre-ve data for P-eIF2-α normalized to eIF2-α in aorta andMRA, n=4; B–C, G–H. CHOPmRNA
e data respectively in aorta andMRA, n=4; D–E, I–J. ATF6mRNA levels, normalized to 18S
ta andMRA from control (C) and p47phox−/−mice untreated or treatedwith tunicamycin
b 0.05 for p47phox−/−+ Tunica vs. C + Tunica.
Fig. 7. Endothelium dependent relaxation, eNOS and NADPH oxidase in MRA from control and p47phox−/− (p47−/−) mice. A. Endothelium dependent relaxation (EDR) in response to
ACh, n= 6; B. EDR in response to ACh in the presence of apocynin (Apo), n= 6; C, D.Western blot analysis for P-eNOS and T-eNOS, normalized to β-actin, n= 4, and eNOSmRNA levels,
normalized to 18S rRNA, n= 6; E. Nox2mRNA levels, normalized to 18S rRNA, n= 6; F. NADPH oxidase activity measured in tissue lysates of vessels from control and p47phox−/−mice
injectedwith saline or tunicamycin, n=5. *P b 0.05 for control+ Tunica or p47 phox−/−+ Tunica vs. control andp47phox−/−; #Pb 0.05 for control+ Tunica vs. p47 phox−/−+ Tunica;
$P b 0.05 for p47phox−/− vs. p47phox−/−+ Tunica.
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(Tudca, 500 μg/mL) [42,43] or phenylbutyric acid (PBA, 0.1 mM) [44]
or in the presence of the p38 MAPK inhibitor, SB203580 (10 μM). We
tested the induction of ER stress by studying ER stress markers expres-
sion in a time course experiment of 6, 8, 10 and 18 h with tunicamycin
(1 μg/mL) and observed that incubation for 6 h was enough to trigger
ER stress induction.
To perform transient transfection experiments, ECs were grown at
70% conﬂuency in 12-well culture dishes and co-transfected with 1 μg
of the reporter plasmid pGL2-eNOS Promoter-Luciferase (which con-
tains a 1621 base pair fragment of human eNOS proximal promoter
driving the luciferase gene), 0.25 μg of the reporter plasmid pRL-TK(Promega) in the presence or absence of 0.5 μg of the mammalian ex-
pression vectors pcDNA1-CHOP or pcDNA3.1-ATF6 using lipofectamine
LTX and Plus transfection reagents (Invitrogen) and transfection was
performed following the manufacturer's instructions. The plasmids
pGL2-eNOS Promoter and pcDNA1-CHOP were purchased from
Addgene (ref. 19297 and ref. 21902, respectively). Transfection was
followed by an incubation of 6 h with vehicle or with tunicamycin in
the presence or absence of ER stress inhibitors. At the end of the treat-
ment, cells were lysed in lysis buffer (Promega), and luciferase and
renilla activities were measured with the dual Luciferase Assay System
(Promega) with a luminometer (Fluoroskan Ascent FL, Labsystems).
The renilla activity was used to normalize the transfection efﬁciency.
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Endothelial cellswere transfectedwith scrambled siRNA (sc-37007),
siRNAs against murine gp91-phox (sc-35504) or Nox4 (sc-41587)
(Santa Cruz Biotechnology, Inc) following the manufacturer's instruc-
tions and using lipofectamine LTX and Plus transfection reagents. After
18 h of transfection, the media was replaced, and, 24 h later cells were
incubated with or without tunicamycin for 6 h and then assayed for
Nox2 or Nox4 mRNA levels, respectively, by real time PCR.
4.3. Impaired DNA analysis by Comet assay
The presence of DNA damage was examined by single-cell electro-
phoresis (Comet assay) by the manufacturer's protocol (OxiSelect
Comet Assay Kit; Cell Biolabs, Inc., San Diego, CA). Brieﬂy, endothelial
cells were treatedwith tunicamycin for 6 hwith orwithout ER stress in-
hibitors. After the culture period, the cells were harvested and washed
with PBS, cell suspension was mixed with agarose at 37 °C, and 75 μL
of this mixture was instantly added to comet slides. Slides were
immersed in lysis buffer at 4 °C for 1 h and then replaced with pre-
chilled alkaline buffer and placed at 4 °C for 30min followed by electro-
phoresis (35 V for 15min) in a horizontal electrophoresis chamber ﬁlled
with Tris borate EDTA (TBE) buffer. Then, slides were transferred to a
container ﬁlled with cold water for 2 to 4 min and then placed in 70%
ethanol for 5 min and air dried overnight at room temperature. After
staining with Vista Green DNA dye for 15 min at room temperature,
comets were observed by ﬂuorescent microscopy (Nikon, Tokyo,
Japan) with ×20 magniﬁcation. The images were analyzed using the
software NIS-Elements BR 3.0 (Nikon, Tokyo, Japan).
4.4. General protocol in mice
All experiments were performed according to the American Guide-
lines for the Ethical Care of Animals and were approved by Tulane
University Animal Care and Use Committee. The mice, C57BL/6J and
B6(Cg)-Ncf1m1J/J (p47phox−/−), 8 weeks-old males, were purchased
from Jackson Laboratories (Bar Harbor, ME), housed in groups of ﬁve
and maintained at a temperature of 23 °C with 12 h light/dark cycle.
Mice were fed on a solid standard diet (Na+ content 0.4%) and water.
The mice were divided into four groups: 1) control group (control
received saline, n = 12); 2) control group that received intra-
peritoneal injection of tunicamycin (Tunica, 0.75 mg/kg, 2 injections/
week for two weeks, control + Tunica, n = 12); 3) p47phox−/−
group that received saline, n = 12 and 4) p47phox−/− group that re-
ceived intra-peritoneal injection of tunicamycin (Tunica, 0.75 mg/kg, 2
injections/week for two weeks, p47phox−/−+ Tunica, n = 12).
At the end of the treatment period, mice were euthanized using an
overdose of isoﬂurane (100%) followed by thoracotomy to ensure
death of the animals. This method is chosen because it is the least trau-
matic. This method is consistent with the recommendation of the Panel
on Euthanasia of the American Veterinary Medical Association with the
AVMA guidelines on euthanasia.
Organs like aorta, heart and mesenteric resistance arteries (MRA)
were harvested immediately, placed in PSS solution (composition in
mM: NaCl 118; KCl 4.7; CaCl2 2.5; KH2PO4 1.2; MgSO4 × 7H2O 1.2;
NaHCO3 25 and glucose 11), pH = 7.4 or processed appropriately for
further studies.
4.5. Systolic blood pressure (SBP) by tail-cuff method
The systolic blood pressure (SBP) was measured at the end of treat-
ment using the CODA tail-cuff blood pressure system (Kent Scientiﬁc,
Torrington, USA) [51]. Arterial blood pressure measurements were per-
formed at the same time of the day (between 9 a.m. and 11 a.m.) in
order to avoid the inﬂuence of the circadian cycle, and the value for
SBP was obtained by calculating the average of 10 measurements.4.6. Vascular reactivity
Thoracic aorta and MRA from all groups of mice were carefully
cleaned of fat and connective tissue and cut into rings (2mm in length).
Aorta andMRAweremounted in a small vessel dual chambermyograph
for the measurement of isometric tension. Two steel wires (25 μmol/L)
were introduced through the lumen of themesenteric resistance artery
(MRA) and mounted according to the method described by Mulvany
and Halpern [52]. After a 30 min equilibration period in PSS solution
bubbled with carbogen at 37 °C and pH = 7.4, arteries were stretched
to their optimal lumen diameter for active tension development.
After a second 30 min equilibration period, arteries were stimulated
with phenylephrine (PE, 10−5 mol/L) followed by acetylcholine (ACh,
10−6 mol/L) to assess endothelial function. After pre-constriction with
PE (10−4 mol/L) and steady maximal contraction, cumulative concen-
tration response curves were obtained for ACh and SNP (1 × 10−8 to
3 × 10−5 mol/L). The arterial lumen diameter and the contraction in re-
sponse to PE were similar in all groups of mice.
To determine the role of eNOS and NADPH oxidase in impaired
endothelium-dependent relaxation in mouse vessels, aorta and MRA
were incubated with L-NAME (100 μmol/L) or apocynin (100 μmol/L)
for 30 min and then endothelium-dependent relaxation was assessed
after pre-contraction with PE.
4.7. Western blot analysis
Mice were sacriﬁced and heart, aorta and MRA were immediately
harvested and frozen in liquid nitrogen and then stored at−80 °C. En-
dothelial cells and tissue lysates were prepared as previously described
[53]. Western blot analysis for P-eNOS, T-eNOS, P-PERK, T-PERK,
BiP(GRP78), P-eIF2-α, T-eIF2-α, CHOP, P-p38 and T-p38MAPK, P-
ERK1/2 and T-ERK1/2 (1:1000 dilution, Cell Signaling Technology, Inc,
USA), and ATF6, HuR or β-actin (1:500 dilution, Santa Cruz Biotechnol-
ogy, Inc) was performed using speciﬁc antibodies as previously de-
scribed [53].
4.8. RT and real-time PCR analysis
CHOP, ATF6, Nox and eNOS mRNA levels were determined in aorta,
MRA and heart samples from all groups as previously described
[51]. The RNA extraction from endothelial cells was obtained by using
TRIzol (Invitrogen). A total of 1 μg of DNAse I-treated RNA was
reverse-transcribed into cDNA using the High Capacity cDNA Archive
Kit (Applied Biosystems, Foster City, California, USA) in a 20 μL reaction.
Assays-on-Demand (Applied Biosystems) of TaqMan ﬂuorescent real
time PCR primers and probes were used for Chop (Mm00492097_
m1), Atf6 (Mm01295317_m1), Nox-2 (Mm01287743_m1), Nox-4
(Mm00479246_m1) and Nos3 (Mm00435217_m1), and 18S rRNA
(Hs99999901_s1), which was used as endogenous control in tissues or
cells respectively, to normalize the results. Quantitative RT-PCRwas car-
ried out in an ABI PRISM 7000 Sequence Detection System (Applied
Biosystems) using the following conditions: 2 min at 50 °C, 10 min at
95 °C followed by 40 cycles of 15 s at 95 °C and 1 min at 60 °C. Relative
mRNA levels were determined using the 2−ΔΔCt method. Results are
expressed as the relative expression of mRNA in tunicamycin treated
mice compared with untreated mice.
4.9. NADPH oxidase activity assay
Superoxide anion levels generated by NADPH oxidase activity were
measured in mouse endothelial cells and in lysates of tissues prepared
in sucrose buffer containing KH2PO4 50 mmol/L, EGTA 1 mmol/L, su-
crose 150 mmol/L; pH= 7.0 and protease inhibitor cocktail (complete
mini, Roche Diagnostics, IN, USA). As a negative control of NADPH oxi-
dase activity, we used cells pre-treated with apocynin (100 μmol/L).
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ing 1% SDS, 1% NP-40, 1 mmol/L Na3VO4, 1 mmol/L DTT and 1× prote-
ase inhibitor cocktail complete C (Roche) using a Tissue Dounce
homogenizer on ice, and aliquots of the homogenateswere used imme-
diately or stored at −80 °C. To start the assay, a volume of 100 μL of
each lysate was used in a total volume of 1 mL PBS buffer preheated at
37 °C and O2− production was measured in the presence of 5 μmol/L of
lucigenin and 100 μmol/L of NADPH. Chemiluminescence was deter-
mined every 30 s for 10–15 min in a luminometer (Turner Biosystems
20/20, single tube luminometer) until enzymatic activity reached a
plateau. A blank was subtracted from each sample prior to adding
lucigenin. The area under the curvewas used to quantify chemilumines-
cence. Data are expressed as relative light units (RLU) normalized to
protein content (μg protein).
4.10. Detection of ROS by ﬂuorescence microscopy
The oxidative ﬂuorescent dye dihydroethidium (DHE) was used to
evaluate O2.− production in situ in endothelial cells. Hydroethidine free-
ly permeates cells and is oxidized in the presence of O2− to ethidiumbro-
mide, which is trapped by intercalation with DNA. Brieﬂy, coronary
endothelial cells were plated on special cell chambers for microscopy
analysis and incubated with tunicamycin with or without ER stress in-
hibitors or apocynin for 6 h. Afterwards, cells were loaded with DHE
(10 μM) in cell culturemedium for 30min at 37 °C and 5% of CO2. Images
were then acquired with a ﬂuorescence microscope (Nikon Eclipse
T300, objective ×20), captured using a digital spot camera (Diagnostic)
and processed using Metamorph image analysis software. Non-
stimulated endothelial cells were daily imaged in parallel using the
same image settings during the course of the study. DHE ﬂuorescence
was quantiﬁed in individual cell nuclei (number of nuclei 10–20/
image/experimental condition) and averaged. Then, we assigned the
value 1 to the control situation and expressed the effects of the different
drugs as fold increase over control.
4.11. Nitrite assay
Endothelial cells were plated into six-well plates, cultured until con-
ﬂuence and then PBA, Tudca, L-NAME (100 μmol/L) or apocynin
(100 μmol/L) were added 1 h before incubation with tunicamycin
for 6 h. Finally, treated cells were incubated for 30 min with ACh
(10−6 mol/L) and supernatants were harvested. NO production was
determined by measuring nitrite content in 225 μL from each well
with 75 μL of Griess reagent. Absorbance wasmeasured and nitrite con-
centration was determined by interpolation of a calibration curve for
standard sodium nitrite concentration versus absorbance.
4.12. Fluorescence in situ hybridization (FISH) RNA
The FISH analysis target was a 476-bp DNA fragment containing
bases from 2821 to 3299 of mouse eNOS included in the NCBI Reference
SequenceNM_008713.4, whichwas generated by ampliﬁcation using as
a template the reverse transcribed cDNA from total RNA extracted from
heart tissue and the oligonucleotides: eNOSF: 5′-GCCCCGGTACTACTCT
GTCA-3′ and eNOSR: 5′-CTGTCCTCAGGAGGTCTTGC-3′. The 476 bp
amplicon was puriﬁed from agarose gel and cloned into pGEM-T vector
(Promega, Madison, WI, USA) and veriﬁed subsequently by sequencing
using the T7 primer. Two clones of p-GEM-T-eNOS (476 bp) construct
containing the insert in opposite directionswere picked in order to syn-
thesize the antisense probe for eNOS mRNA detection and the sense
probe as a negative control for hybridization assay.
The probes were synthesized and labeled with Alexa Fluor 594 dye
using the FISH Tag RNA kit (Molecular probes, Invitrogen). The RNA
probe synthesis and labeling with ﬂuorescent dye, hybridization
and detection of ﬂuorescent signals were performed as described by
the kit protocol and following the manufacturer's instructions. Theﬂuorescence intensity was quantiﬁed in captured images, taken with a
ﬂuorescent microscope (Nikon, Tokyo, Japan) with ×40 magniﬁcation,
using the software NIS-Elements BR 3.0 (Nikon, Tokyo, Japan).
4.13. Drugs
Phenylbutyric acid (PBA), phenylephrine hydrochloride, acetylcho-
line chloride, sodium nitroprusside, U46619, apocynin, NADPH and L-
NAME were obtained from Sigma-Aldrich (St. Louis, MO, USA).
Tauroursodeoxycholic acid (Tudca), tunicamycin and SB203580 (4-(4-
ﬂuorophenyl)-2-(4-methylsulﬁnylphenyl)-5-(4-pyridyl)1H-imid-
azole) were purchased from Calbiochem (USA and Canada). Stock
solutions of drugs were prepared in ultrapure water or in DMSO fol-
lowing the manufacturer's instructions, stored at−20 °C and appro-
priate dilutions were made on the day of the experiment.
4.14. Statistical analysis
Data are expressed asmean± SEM. Concentration–response curves
were analyzed using theGraphPad Prism4.0 software (GraphPad, USA).
One-way or 2-way ANOVAwas used to compare each parameter when
appropriate. Values of P≤ 0.05 were considered signiﬁcant. Differences
between speciﬁed groupswere analyzed using the Student's t test (two-
tailed) comparing the two groups with P ≤ 0.05 considered as statisti-
cally signiﬁcant.
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